Cambridge, UK - PiR was delighted to host senior representatives from the life sciences community, together with the industry trade press, at its CEO Breakfast Forum, which took place at the Chesterford Research Park, Cambridge, United Kingdom on 17 January.

The speaker, Dr Darrin M Disley is a parallel entrepreneur, investor and enterprise champion who has started, grown and raised over $320m for 15 businesses and invested in over 40 others. This includes Horizon Discovery Group plc where he is CEO, a company that provides products, services and research programs to organisations involved in genomics research, the development of personalised medicines, and cell and gene therapies. His address, The Impact of the New Biology: from Genomics to Personalised Medicine', was wide ranging, covering developments in personalised medicine, funding and how to run a successful life sciences startup.

To read the event summary, please visit the PiR website here: http://www.pir-resourcing.com/news/pir-breakfast-briefing-personalised-medicine-dr-darrin-disley